Adagio Medical Holdings (ADGM) Total Current Liabilities (2023 - 2026)
Adagio Medical Holdings (ADGM) reported Total Current Liabilities of $8.6 million for Q1 2026, up 42.74% on a YoY basis from $6.0 million in Q1 2025, and up 4.13% sequentially from $8.2 million in Q4 2025.
Adagio Medical Holdings (ADGM) Total Current Liabilities (2023 - 2026) Analysis & Trends
Adagio Medical Holdings (ADGM) has 4 years of Total Current Liabilities data on file, last reported at $8.6 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 42.74% year-over-year to $8.6 million; the trailing twelve-month figure through Mar 2026 stood at $8.6 million (up 42.74% YoY), and the FY2025 full-year result was $8.2 million, up 6.05% from the prior year.
- Total Current Liabilities advanced to $8.6 million in Q1 2026, from $8.2 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $47.2 million in Q4 2023 to a low of $4.9 million in Q2 2025.
- A 4-year average of $12.5 million and a median of $8.1 million in 2024 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities tumbled 83.54% in 2024 and jumped 42.74% in 2026, its largest moves.
- Tracing ADGM's Total Current Liabilities over 4 years: stood at $47.2 million in 2023, then plunged by 83.54% to $7.8 million in 2024, then climbed by 6.05% to $8.2 million in 2025, then gained by 4.13% to $8.6 million in 2026.
- Business Quant data shows ADGM's Total Current Liabilities at $8.6 million in Q1 2026, $8.2 million in Q4 2025, and $9.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 108.68 Bn | 99.46 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 48.26 Bn | 44.58 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 28.39 Bn | 27.28 Bn | 750.30 Mn | 2.22 Bn |
| 7 | GE HealthCare Technologies | 28.22 Bn | 25.93 Bn | 1.98 Bn | 8.53 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | 1.60 Bn |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | 8.70 Bn |
| 10 | Adagio Medical Holdings | 21.45 Mn | 21.45 Mn | - | 8.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.57 Mn |
| Dec 31, 2025 | 8.23 Mn |
| Sep 30, 2025 | 9.70 Mn |
| Jun 30, 2025 | 4.88 Mn |
| Mar 31, 2025 | 6.01 Mn |
| Dec 31, 2024 | 7.76 Mn |
| Sep 30, 2024 | 7.92 Mn |
| Dec 31, 2023 | 47.18 Mn |